
Cefriya-SL 750mg Injection
Marketer
Supermax Laboratories
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefriya-SL 750mg Injection
Combiflox 750mg Injection, a multifaceted antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the entire course, even with symptom improvement, as premature cessation can compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration promote faster recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Cefriya-SL 750mg Injection
Infections caused by bacteria
Major Benefits of Cefriya-SL 750mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefriya-SL 750mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefriya-SL 750mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cefriya-SL 750mg Injection works:
Ceftriaxone and sulbactam, combined as Cefriya-SL 750mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefriya-SL 750mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cefriya-SL, 750mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nonetheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Cefriya-SL 750mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefriya-SL 750mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefriya-SL 750mg Injection use in individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Cefriya-SL 750mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefriya-SL 750mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefriya-SL 750mg Injection :
Omit a Cefriya-SL 750mg Injection dose? Seek your physician's advice.
Facts to Know About Cefriya-SL 750mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
